Search

Search Constraints

You searched for: Author/Creator Sirima, Sodiomon B.

Search Results

1. A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children. Issue 38 (31st August 2016)

2. A review of 65 years of human adenovirus seroprevalence. (3rd June 2019)

3. Antibody-Dependent Cellular Inhibition Is Associated With Reduced Risk Against Febrile Malaria in a Longitudinal Cohort Study Involving Ghanaian Children. (10th April 2015)

4. Clinical Variation of Plasmodium falciparum eba-175, ama-1, and msp-3 Genotypes in Young Children Living in a Seasonally High Malaria Transmission Setting in Burkina Faso. (8th November 2015)

5. Efficacy and Safety of the Mosquitocidal Drug Ivermectin to Prevent Malaria Transmission After Treatment: A Double-Blind, Randomized, Clinical Trial. (19th November 2014)

6. Extended follow-up of children in a phase2b trial of the GMZ2 malaria vaccine. Issue 31 (13th July 2021)

7. Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study. Issue 5 (May 2017)

8. SAFETY AND EFFICACY OF SAR97276A FOR TREATING MALARIA: TWO OPEN-LABEL MULTICENTER PHASE II CLINICAL STUDIES IN AFRICAN CHILDREN AND ADULTS. (12th February 2017)

9. Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso. (January 2021)

10. Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial. (July 2021)